Results 31 to 40 of about 68 (61)

The potential contribution of ranolazine to Torsade de Pointe. [PDF]

J Cardiovasc Dis Res, 2013
Liu Z, Williams RB, Rosen BD.
europepmc   +1 more source

Influence of type 2 diabetes on symbolic analysis and complexity of heart rate variability in men. [PDF]

Diabetol Metab Syndr, 2014
Moura-Tonello SC, Takahashi AC, Francisco CO, Lopes SL, Del Vale AM, Borghi-Silva A, Leal AM, Montano N, Porta A, Catai AM.   +9 more
europepmc   +1 more source

Brazilian Cardiology Society Statement for Management of Pregnancy and Family Planning in Women with Heart Disease - 2020. [PDF]

Arq Bras Cardiol, 2020
Avila WS, Alexandre ERG, Castro ML, Lucena AJG, Marques-Santos C, Freire CMV, Rossi EG, Campanharo FF, Rivera IR, Costa MENC, Rivera MAM, Carvalho RCM, Abzaid A, Moron AF, Ramos AIO, Albuquerque CJDM, Feio CMA, Born D, Silva FBD, Nani FS, Tarasoutchi F, Costa Junior JR, Melo Filho JX, Katz L, Almeida MCC, Grinberg M, Amorim MMR, Melo NR, Medeiros OO, Pomerantzeff PMA, Braga SLN, Cristino SC, Martinez TLDR, Leal TCAT.   +33 more
europepmc   +1 more source

Mind the gap in kidney care: translating what we know into what we do. [PDF]

J Bras Nefrol
Luyckx VA, Tuttle KR, Abdellatif D, Correa-Rotter R, Fung WWS, Haris A, Hsiao LL, Khalife M, Kumaraswami LA, Loud F, Raghavan V, Roumeliotis S, Sierra M, Ulasi I, Wang B, Lui SF, Liakopoulos V, Balducci A, World Kidney Day Joint Steering Committee.   +18 more
europepmc   +1 more source

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial. [PDF]

Front Pharmacol, 2018
Buonerba C, De Placido P, Bruzzese D, Pagliuca M, Ungaro P, Bosso D, Ribera D, Iaccarino S, Scafuri L, Liotti A, Romeo V, Izzo M, Perri F, Casale B, Grimaldi G, Vitrone F, Brunetti A, Terracciano D, Marinelli A, De Placido S, Di Lorenzo G.   +20 more
europepmc   +1 more source

Brazilian Guideline on Dyslipidemias and Prevention of Atherosclerosis - 2025. [PDF]

Arq Bras Cardiol
Rached FH, Miname MH, Rocha VZ, Zimerman A, Cesena FHY, Sposito AC, Santos RDD, Behr PEB, Bianco HT, Alves RJ, Faludi AA, Coutinho EDR, Fonseca FAH, Carvalho LSF, Bertolami A, Rocha AMD, Marte AP, Chagas ACP, Caramelli B, Polanczyk CA, Ferreira CEDS, Serrano Junior CV, Araujo DB, Moriguchi EH, Pinto FJ, Moreira HG, Back IC, Faria Neto JR, Maia KAP, Bertolami MC, Assad MHV, Izar MCO, Barreto MA, Barreto NSF, Silva PGMBE, Pimentel Filho P, Maranhão RC, Kaiser SE, Machado VA, Saraiva JFK.   +39 more
europepmc   +1 more source

La gestione value-based del paziente adulto con Ipertensione Arteriosa Polmonare: Health Technology Assessment di sotatercept. [PDF]

J Prev Med Hyg
Calabrò GE, DE Belvis AG, Bert F, Lo Moro G, Scaioli G, D'Ambrosio F, DE Donno R, Scarfagna C, Ricciardi R, Vizza D, D'Alto M, Ghio S, Limongelli G, Poscia R, Sciattella P, Paoletti M, Marcellusi A, Ricciardi W.   +17 more
europepmc   +1 more source

[Review of the interference between the most commonly prescribed drugs and clinical analyses at the Primary Health Care Centre of L'Hospitalet de Llobregat]. [PDF]

Aten Primaria, 2006
Vargas R, Torné N, Travé P, March M, Rodríguez G, Calero S.   +5 more
europepmc   +1 more source

[Fixed drug combinations in hypertension: a budget impact analysis for the Spanish Health System on the marketing of a fixed combination of olmesartan/amlodipine]. [PDF]

Aten Primaria, 2011
Belén Ferro-Rey M, Roca-Cusachs A, Sicras-Mainar A, Alvarez-Martín C, de Salas-Cansado M.   +4 more
europepmc   +1 more source

Normal erythrocyte calpain I activity on membrane proteins under near-physiological conditions in patients with essential hypertension. [PDF]

Sao Paulo Med J, 2002
Dantas de Medeiros TM, Ortega KC, Mion D, Nonoyama K, Barretto OC.   +4 more
europepmc   +1 more source